AbbVie
Patents, Design & Utilities

Last updated:

List of all AbbVie patents 265 in total

Status Patent
Application
Utility: METHODS OF TREATMENT OF DISEASES IN WHICH IL-13 ACTIVITY IS DETRIMENTAL USING ANTI-IL-13 ANTIBODIES External link
Filling date: 12 Sep 2025 Issue date: 8 Sep 2022
Application
Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF External link
Filling date: 12 Sep 2025 Issue date: 8 Sep 2022
Application
Utility: METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS External link
Filling date: 12 Sep 2025 Issue date: 1 Sep 2022
Application
Utility: MEDICATION PACKAGING AND DISPENSING SYSTEM External link
Filling date: 12 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF External link
Filling date: 12 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR External link
Filling date: 12 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: ANTI-CD40 ANTIBODY DRUG CONJUGATES External link
Filling date: 12 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE External link
Filling date: 12 Sep 2025 Issue date: 18 Aug 2022
Application
Utility: METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS External link
Filling date: 12 Sep 2025 Issue date: 18 Aug 2022
Application
Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF External link
Filling date: 12 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: PRODRUG MODULATORS OF THE INTEGRATED STRESS PATHWAY External link
Filling date: 12 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS External link
Filling date: 12 Sep 2025 Issue date: 28 Jul 2022
Application
Utility: Anti-EGFR Antibody-Drug Conjugates External link
Filling date: 12 Sep 2025 Issue date: 21 Jul 2022
Grant
Utility: Isolation and purification of anti-IL-13 antibodies using protein a affinity chromatography External link
Filling date: 12 Sep 2025 Issue date: 19 Jul 2022
Grant
Utility: Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies External link
Filling date: 12 Sep 2025 Issue date: 19 Jul 2022
Application
Utility: ENZYME COMPOSITIONS WITH REDUCED VIRAL AND MICROBIAL CONTAMINATION External link
Filling date: 12 Sep 2025 Issue date: 7 Jul 2022
Application
Utility: BICYCLIC PYRAZOLE BRUTON'S TYROSINE KINASE INHIBITORS External link
Filling date: 12 Sep 2025 Issue date: 7 Jul 2022
Application
Utility: COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR External link
Filling date: 12 Sep 2025 Issue date: 7 Jul 2022
Grant
Utility: Melt-extruded solid dispersions containing an apoptosis-inducing agent External link
Filling date: 12 Sep 2025 Issue date: 28 Jun 2022
Grant
Utility: Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof External link
Filling date: 12 Sep 2025 Issue date: 21 Jun 2022
Grant
Utility: Medication packaging and dispensing system External link
Filling date: 12 Sep 2025 Issue date: 14 Jun 2022
Grant
Design: Sleeve container External link
Filling date: 12 Sep 2025 Issue date: 14 Jun 2022
Grant
Utility: Methods of treating heavy menstrual bleeding External link
Filling date: 12 Sep 2025 Issue date: 31 May 2022
Grant
Utility: Interleukin-13 binding proteins External link
Filling date: 12 Sep 2025 Issue date: 31 May 2022
Application
Utility: METHODS OF TREATING PARKINSON'S DISEASE External link
Filling date: 12 Sep 2025 Issue date: 19 May 2022
Grant
Design: Sleeve container External link
Filling date: 12 Sep 2025 Issue date: 17 May 2022
Application
Utility: SOLID DISPERSIONS CONTAINING AN APOPTOSIS-INDUCING AGENT External link
Filling date: 12 Sep 2025 Issue date: 28 Apr 2022
Grant
Utility: Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose External link
Filling date: 12 Sep 2025 Issue date: 26 Apr 2022
Application
Utility: MODULATORS OF THE INTEGRATED STRESS PATHWAY External link
Filling date: 12 Sep 2025 Issue date: 7 Apr 2022
Grant
Utility: Dosing regimens for use in treating myelofibrosis and MPN-related disorders with navitoclax External link
Filling date: 12 Sep 2025 Issue date: 29 Mar 2022
Grant
Utility: Enzyme compositions with reduced viral and microbial contamination External link
Filling date: 12 Sep 2025 Issue date: 22 Mar 2022
Application
Utility: METHODS OF TREATING HEAVY MENSTRUAL BLEEDING External link
Filling date: 12 Sep 2025 Issue date: 17 Mar 2022
Application
Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF External link
Filling date: 12 Sep 2025 Issue date: 10 Mar 2022
Grant
Utility: Solid pharmaceutical compositions for treating HCV External link
Filling date: 12 Sep 2025 Issue date: 15 Feb 2022
Grant
Utility: Crystal forms External link
Filling date: 12 Sep 2025 Issue date: 8 Feb 2022
Application
Utility: METHODS FOR TREATING SPINAL CORD INJURY AND PAIN External link
Filling date: 12 Sep 2025 Issue date: 27 Jan 2022
Application
Utility: WEARABLE AUTOMATIC INJECTION DEVICE FOR CONTROLLED ADMINISTRATION OF THERAPEUTIC AGENTS External link
Filling date: 12 Sep 2025 Issue date: 27 Jan 2022
Application
Utility: ANTI-ALPHA-4-BETA-7 ANTIBODIES External link
Filling date: 12 Sep 2025 Issue date: 20 Jan 2022
Application
Utility: Bromodomain Inhibitors External link
Filling date: 12 Sep 2025 Issue date: 20 Jan 2022
Application
Utility: MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN AND USES THEREOF External link
Filling date: 12 Sep 2025 Issue date: 20 Jan 2022
Application
Utility: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES External link
Filling date: 12 Sep 2025 Issue date: 30 Dec 2021
Application
Utility: MODULATORS OF THE INTEGRATED STRESS PATHWAY External link
Filling date: 12 Sep 2025 Issue date: 23 Dec 2021
Application
Utility: Methods of Treating Acute HCV External link
Filling date: 12 Sep 2025 Issue date: 16 Dec 2021
Grant
Utility: Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof External link
Filling date: 12 Sep 2025 Issue date: 14 Dec 2021
Application
Utility: SYRINGE WITH TWO-STAGE SEALING PRESSURE External link
Filling date: 12 Sep 2025 Issue date: 9 Dec 2021
Application
Utility: METHODS OF TREATMENT OF DISEASES IN WHICH IL-13 ACTIVITY IS DETRIMENTAL USING ANTI-IL-13 ANTIBODIES External link
Filling date: 12 Sep 2025 Issue date: 9 Dec 2021
Grant
Utility: Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof External link
Filling date: 12 Sep 2025 Issue date: 30 Nov 2021
Application
Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF External link
Filling date: 12 Sep 2025 Issue date: 25 Nov 2021
Application
Utility: METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS External link
Filling date: 12 Sep 2025 Issue date: 25 Nov 2021
Application
Utility: MODULATORS OF THE INTEGRATED STRESS PATHWAY External link
Filling date: 12 Sep 2025 Issue date: 25 Nov 2021

Showing 1 to 50 of 265 patents.